Vimarsana
Biggest News Aggregation in the World

Collaborative Medicinal Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Collaborative Medicinal Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Collaborative Medicinal Development Today - Breaking & Trending Today

Adding Fluoxetine to Therapy Not Superior to Therapy Alone in Depressed Teens - Vimarsana News

Adding Fluoxetine to Therapy Not Superior to Therapy Alone in Depressed Teens

The addition of fluoxetine to CBT did not further reduce depressive symptoms in young people with moderate-to-severe depression.

Researchers Ask, 'Why Do Antidepressants Stop Working?' - Vimarsana News

Researchers Ask, 'Why Do Antidepressants Stop Working?'

An international group of researchers explored possible explanations for why long-term users of antidepressants become chronically depressed.

Parkinson's Disease: Global Therapeutic Development Analysis H2 2020 including Drug Profiles and Key Company Reviews - Vimarsana News

Parkinson's Disease: Global Therapeutic Development Analysis H2 2020 including Drug Profiles and Key Company Reviews

Share this article Share this article ResearchAndMarkets.com's offering. Report Highlights The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 11, 48, 62, 4, 224, 97 and 9 respectively. Similarly, the Universitie...